Trevi Therapeutics, 195 Church Street, 14th Floor, New Haven, CT 06510. Phone: 203-304-2499
For investor-related questions, please visit “Investor Contacts” under the “Investor Resources” section of our corporate website.
The Company was founded in 2011.
Trevi Therapeutics’ common stock began trading on the Nasdaq Global Market on May 7, 2019.
Trevi Therapeutics’ common stock is listed on the NASDAQ Global Market under the symbol “TRVI”.
The transfer agent and registrar for the common stock of Trevi Therapeutics, Inc. stock is
Computershare Trust Company, N.A.
P.O. Box 505000
Louisville, KY 40233-5000
By Overnight Delivery:
462 South 4th Street, Suite 1600
Louisville, KY 40202
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
Online: Computershare Investor Services, https://www-us.computershare.com/investor/Contact Phone: (800) 736-3001 (US, Canada, Puerto Rico); (781) 575-3100 (non-US)
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare, 462 South 4th Street, Louisville, KY 40202.
To replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A. The transfer agent can look up your records and make any necessary adjustments.
The Company does not have a direct stock purchase plan.
Ernst & Young LLP, Stamford, CT.
Please visit our webpage at www.trevitherapeutics.com.
The press release archive can be viewed on the “Press Releases” section under the “Investors” tab, and financial reports are available under the “SEC Filings” page under the “Investors” tab located at our website www.trevitherapeutics.com.
Please access the “Investor Alerts” page to be notified of Company press releases and other information.